Duo Oncology

Pittsburgh, PA · Founded 2020 · Privately Held (backing)

Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. Duo Oncology is based in Pittsburgh, PA and was founded in 2020. It was valued at $25 million at its seed round in Jun 2025, the last priced event on record. It has raised $13.1 million across 3 recorded rounds; the latest was a $1.4 million seed round in Jun 2025.

PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$13.1M
Last round
Seed Round
Jun 2025
What is Duo Oncology worth?
$25.0MPrivateMarketView mark · Oct 2026

Valued at $25.0M at its seed round, Jun 2025. Nothing has traded since.

Free account
More of Duo Oncology with a free account
  • ·Watch Duo Oncology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Duo Oncology funding history

3 rounds
DateRoundRaisedPost-money
Jun 2025Seed Round$1.4M▮
Jan 2023Seed Round$4.3M▮
Feb 2021Seed Round$1.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Duo Oncology valuation

Duo Oncology was valued at $25 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Duo Oncology raised?

Duo Oncology has raised $13.1 million across 3 recorded rounds since 2021. The largest was a $4.3 million seed round in Jan 2023; the most recent was a $1.4 million seed round in Jun 2025.

Duo Oncology has filed 4 Form Ds with the SEC since 2021, most recently in Jun 2025 ($400,000 sold to 8 investors).

How Duo Oncology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Duo Oncology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Duo Oncology

What is Duo Oncology worth?
Duo Oncology is valued at $25.0M as of Oct 2026. Valued at $25.0M at its seed round, Jun 2025. Nothing has traded since.
How much has Duo Oncology raised?
Duo Oncology has raised $13.1M in total funding across 3 recorded rounds.
When did Duo Oncology last raise?
Duo Oncology last raised in Jun 2025 (Seed Round), raising $1.4M.